Market News
Smart Trading. Simplified.
Stock Market Whiz Kid Works 1 Hour a Day. Makes Millions.
He was living with his parents. Two years later he had $5 million to play with - all because of this 1 EXTRA INCOME strategy.
To see how he did it click here.
5 Top Stock Picks for the Recovery
The economy is on its way to normalcy. After over a year of pandemic quarantines, the FDA and other agencies are preparing for recovery. The threshold for herd immunity is expected to be reached soon. That should translate to more consumers demanding more goods and services, so which are the top stock picks for recovery? […]
"The Biggest Drug Ever"
On August 23, 2018, a small biotech won a patent for a treatment that could help as many as 50 million people and save the U.S. as much as $20 TRILLION. Jim Cramer says a drug like this would be "The Biggest Drug Ever."
Our research shows that anyone who gets in today could turn every $1,000 into $1.1 million >>>
Why Does Cathie Wood Like Palantir?
Cathie Wood is a prolific investor whose Ark Invest firm was among the most successful through the pandemic. Wood makes her investment choices in actively managed exchange-traded funds (ETFs). Her philosophy is to invest in disruptive companies that have long-term potential in the future of society. With that in mind, some investors wonder, why does […]
New "Trojan Horse" Treatment Could Cost $2 Million
The New York Times reports new treatment "will change medicine."
Wall Street thinks it could be a $2 TRILLION market worldwide.
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
How High Can DraftKings Stock Go?
DraftKings stock has been volatile this year. After an extremely successful 2020, many investors believe that the company can maintain growth. This idea brings up an important question: how high can DraftKings stock go? Has it already reached its tipping point, or does it still have room to move upward? DraftKings excels at three things: […]
Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER?
Have you seen this new extra-income hack yet?
Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new strategy. Some of them are retiring from their jobs because of it. Others have paid off all their debt and bought their dream homes.
You can see their stories for yourself right here.
Ocugen Stock Forecast
Ocugen Inc (NASDAQ:OCGN) is working through phase 3 clinical trials for its coronavirus vaccine candidate. The company’s Covaxin (created in partnership with Bharat Biotech) so far shows 78 percent efficacy against COVID-19 with 100 percent protection against it escalating into a severe illness. The agreement gives the company 45 percent of any Covaxin profits. Its […]
Tiny Biotech Creates $2 Trillion Drug
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
Is TBK Stock Price Forecast To Rise?
TBK Stock Price Forecast: Triumph Bancorp, Inc. is a financial services company operating out of Dallas, Texas, which, through its five subsidiary business brands, offers a range of services including asset-based banking, factoring, payments processing, commercial finance, and insurance. The Shift to Transportation Since 2019, Triumph Bancorp has focused its efforts on the transportation and […]
Former Broker Dealer Teaches Traders...
"If I had a stadium filled with my former students, I'd teach them how to spot and trade within Vomma Zone."
Don Kaufman, 23-Year Professional Trader and Educator at TD Ameritrade, shares it all.
Join Don as he breaks down this special zone he calls the "Vomma Zone."
Watch him share the exact playbook he uses to extract consistent profits from an increasingly volatile market.
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment